CIK 0001490978
- Large accelerated filer
Schrodinger, Inc.
Sign in to watch- Ticker
- SDGR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954284541
- Phone
- +1 503-299-1150
- Business address
- 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
- 4 Derivatives Options or other derivatives
- 4 Option exercise EVP, CTO & COO, Software acquired 5,574 shares (option exercise)
- 4 Open-market sale EVP & CFO sold 3,315 shares at $26.35 ($87,360)
- 4 Derivatives Options or other derivatives
- 4 Grant or award SVP & Controller acquired 7,313 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP, CLO & CPO sold 758 shares at $28.29 ($21,444)
- 4 Planned sale See Remarks sold 1,205 shares at $27.55 ($33,198)
- 4 Planned sale SVP & Controller sold 787 shares at $28.29 ($22,264)
- 4 Planned sale EVP, CTO & COO, Software sold 901 shares at $28.29 ($25,489)
- 4 Option exercise SVP & Controller acquired 4,545 shares (option exercise)
- 4 Grant or award Chief Medical Officer acquired 15,000 shares (grant or award)
- 4 Planned sale EVP & Chief Technology Officer sold 10,000 shares at $40.06 ($400,642)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, CLO & CPO sold 12,040 shares at $50.00 ($602,000)
- 4 Grant or award Director acquired 6,250 shares (grant or award)
Page 5 of 17 · 326 filings